Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Abstract Text:

Kumi Oshima,Yoshinobu Kanda,Hideki Nakasone,Shunya Arai,Nahoko Nishimoto,Hiroyuki Sato,Takuro Watanabe,Noriko Hosoya,Koji Izutsu,Takashi Asai,Akira Hangaishi,Toru Motokura,Shigeru Chiba,Mineo Kurokawa,

Cyclosporine A (CsA) is the mainstay of pharmacologic prevention of acute graft-versus-host disease (GVHD). We previously reported that continuous infusion of CsA with a target blood level between 250 and 400 ng/ml significantly increased the incidence of acute GVHD compared to twice-daily infusion with a target trough level between 150 and 300 ng/ml. Thus, we raised the target level of CsA continuous infusion to 450-550 ng/ml. We treated 33 patients with the higher target level (CsA500) and compared the efficacy and toxicity with those in the 33 historical control patients (CsA300 group). Other transplantation procedures were not changed. The patients' characteristics were equivalent. The average CsA concentration was adjusted around 500 ng/ml and the actual daily dose was maintained at the initial dose (CsA 3mg/kg/day). Toxicities were equivalently observed among the two groups. The incidence of grades II-IV acute GVHD was significantly lower in the CsA500 group (27 vs. 52%, P = 0.033). The target level of CsA was identified as an independent significant risk factor for grades II-IV acute GVHD (P = 0.039), adjusted for the presence of HLA mismatch. The incidence of chronic GVHD was also decreased in the CsA500 group (47 vs. 73%, P = 0.016). We conclude that the toxicity of the continuous CsA infusion with a target level of 450-550 ng/ml is acceptable and the efficacy to prevent acute GVHD is significant. A larger comparative study is warranted to confirm these findings. Am. J. Hematol., 2008. (c) 2007 Wiley-Liss, Inc.

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Publishing Authors By Initials

K Oshima,Y Kanda,H Nakasone,S Arai,N Nishimoto,H Sato,T Watanabe,N Hosoya,K Izutsu,T Asai,A Hangaishi,T Motokura,S Chiba,M Kurokawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of hematology

VOLUME: 83

Page Numbers: 226-32

Journal Abbreviation: Am. J. Hematol.

ISSN: 0361-8609

DAY: 4

MONTH: Mar

YEAR: 2008

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7610369

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.

AFFILIATION: Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Hematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level Related Publications

• 4 x 1204 holographic switching with an optically addressed spatial light modulator.
• Comparison of the toxicity of p-dichlorobenzene (p-DCB) administered to male F344 rats orally or by the inhalation route.
• Compartmentalized regulations of ion channels in the heart.
• Coordinated peripheral neuronal activities among the different regions of the digestive tract in aplysia.
• Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
• Disseminated adenovirus disease by multiple adenovirus serotypes following allogeneic hematopoietic stem cell transplantation.
• Extension of distance measurement range in a sinusoidal wavelength-scanning interferometer using a liquid-crystal wavelength filter with double feedback control.
• Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice.
• FDG-PET in T-cell and NK-cell neoplasms.
• False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.
• Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate.
• Immunohistological detection of T antigen and ABH blood group antigens in upper urinary tract tumours.
• Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
• Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
• Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia.
• Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9.
• Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
• Ranitidine: a pilot study in Japan.
• Synaptic potentials recorded in brain slices and their modification by changes in the level of tissue ATP.
• The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
• Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
• Ultrastructural changes associated with reversible and irreversible suppression of electrical activity in olfactory cortex slices.
• [Contact lenses with corrected inside curve. 3. Follow-up studies]
• [Human science. Sex. 4. Sexual and psychological maturity]
• [Median sternotomy in resection of bilateral multiple metastatic lung tumors]
• [The pathogenetic significance of deregulated hematopoietic transcription factors in leukemia]
• [Theoretical and clinical studies on a soft contact lens]
• [Theoretical and clinical studies on hydrophilic contact lenses. IX. Handling and storage of the lens]
• [Theoretical and clinical studies on soft contact lens. 5. Improvement of molecularly combined two-in-one lens]
• [Thrombocytopenia]